Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons
To access this article, please choose from the options below
PII: S0197-4580(06)00084-4
doi:10.1016/j.neurobiolaging.2006.02.018
© 2006 Elsevier Inc. All rights reserved.
